Your browser doesn't support javascript.
loading
Compare CPM-RMI trial: intramyocardial transplantation of autologous bone marrow-derived cd133+ cells and mononuclear cells during coronary artery bypass grafting in patients with recent myocardial infarction: a phase II/III, multicenter, placebo-controlled, randomized, double-blind clinical trial
Cell Journal [Yakhteh]. 2018; 20 (2): 267-277
en Inglés | IMEMR | ID: emr-198738
ABSTRACT

Objective:

The regenerative potential of bone marrow-derived mononuclear cells [MNCs] and CD133+ stem cells in the heart varies in terms of their pro-angiogenic effects. This phase II/III, multicenter and double-blind trial is designed to compare the functional effects of intramyocardial autologous transplantation of both cell types and placebo in patients with recent myocardial infarction [RMI] post-coronary artery bypass graft
Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Tipo de estudio: Ensayo Clínico Controlado Idioma: Inglés Revista: Cell J. [Yakhteh] Año: 2018

Similares

MEDLINE

...
LILACS

LIS

Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Tipo de estudio: Ensayo Clínico Controlado Idioma: Inglés Revista: Cell J. [Yakhteh] Año: 2018